Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Oncology Cytotoxic Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Cytotoxic Drugmarket, defines the market attractiveness level of Oncology Cytotoxic Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncology Cytotoxic Drug industry, describes the types of Oncology Cytotoxic Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Cytotoxic Drug market and the development prospects and opportunities of Oncology Cytotoxic Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Cytotoxic Drug market in Chapter 13.
By Player:
Celgene
Roche
Haosoh Pharma
Sumitomo Dainippon Pharma
Jazz Pharma
Takeda
eisai
Astra Zeneca
Eli Lilly
Spectrum Pharma
Seattle Genetics
Merck
Sanofi
Novartis
By Type:
Injection
Solid Oral Dose Forms
Others
By End-User:
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory
Lung Cancer
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncology Cytotoxic Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncology Cytotoxic Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncology Cytotoxic Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncology Cytotoxic Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncology Cytotoxic Drug Market Analysis and Outlook to 2022
-
7.1 Global Oncology Cytotoxic Drug Consumption (2017-2022)
-
7.2 United States Oncology Cytotoxic Drug Consumption (2017-2022)
-
7.3 Europe Oncology Cytotoxic Drug Consumption (2017-2022)
-
7.4 China Oncology Cytotoxic Drug Consumption (2017-2022)
-
7.5 Japan Oncology Cytotoxic Drug Consumption (2017-2022)
-
7.6 India Oncology Cytotoxic Drug Consumption (2017-2022)
-
7.7 South Korea Oncology Cytotoxic Drug Consumption (2017-2022)
8 Region and Country-wise Oncology Cytotoxic Drug Market Analysis and Outlook to 2028
-
8.1 Global Oncology Cytotoxic Drug Consumption Forecast (2022-2028)
-
8.2 United States Oncology Cytotoxic Drug Consumption Forecast (2022-2028)
-
8.3 Europe Oncology Cytotoxic Drug Consumption Forecast (2022-2028)
-
8.4 China Oncology Cytotoxic Drug Consumption Forecast (2022-2028)
-
8.5 Japan Oncology Cytotoxic Drug Consumption Forecast (2022-2028)
-
8.6 India Oncology Cytotoxic Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Oncology Cytotoxic Drug Consumption Forecast (2022-2028)
9 Global Oncology Cytotoxic Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Oncology Cytotoxic Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Solid Oral Dose Forms Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncology Cytotoxic Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Respiratory Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Lung Cancer Consumption and Growth Rate (2017-2022)
10 Global Oncology Cytotoxic Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Oncology Cytotoxic Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Solid Oral Dose Forms Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncology Cytotoxic Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncology Cytotoxic Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncology Cytotoxic Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncology Cytotoxic Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncology Cytotoxic Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncology Cytotoxic Drug Market Competitive Analysis
-
14.1 Celgene
-
14.1.1 Celgene Company Details
-
14.1.2 Celgene Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Celgene Oncology Cytotoxic Drug Product and Service
-
14.2 Roche
-
14.2.1 Roche Company Details
-
14.2.2 Roche Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Oncology Cytotoxic Drug Product and Service
-
14.3 Haosoh Pharma
-
14.3.1 Haosoh Pharma Company Details
-
14.3.2 Haosoh Pharma Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Haosoh Pharma Oncology Cytotoxic Drug Product and Service
-
14.4 Sumitomo Dainippon Pharma
-
14.4.1 Sumitomo Dainippon Pharma Company Details
-
14.4.2 Sumitomo Dainippon Pharma Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sumitomo Dainippon Pharma Oncology Cytotoxic Drug Product and Service
-
14.5 Jazz Pharma
-
14.5.1 Jazz Pharma Company Details
-
14.5.2 Jazz Pharma Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Jazz Pharma Oncology Cytotoxic Drug Product and Service
-
14.6 Takeda
-
14.6.1 Takeda Company Details
-
14.6.2 Takeda Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Oncology Cytotoxic Drug Product and Service
-
14.7 eisai
-
14.7.1 eisai Company Details
-
14.7.2 eisai Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 eisai Oncology Cytotoxic Drug Product and Service
-
14.8 Astra Zeneca
-
14.8.1 Astra Zeneca Company Details
-
14.8.2 Astra Zeneca Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Astra Zeneca Oncology Cytotoxic Drug Product and Service
-
14.9 Eli Lilly
-
14.9.1 Eli Lilly Company Details
-
14.9.2 Eli Lilly Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Eli Lilly Oncology Cytotoxic Drug Product and Service
-
14.10 Spectrum Pharma
-
14.10.1 Spectrum Pharma Company Details
-
14.10.2 Spectrum Pharma Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Spectrum Pharma Oncology Cytotoxic Drug Product and Service
-
14.11 Seattle Genetics
-
14.11.1 Seattle Genetics Company Details
-
14.11.2 Seattle Genetics Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Seattle Genetics Oncology Cytotoxic Drug Product and Service
-
14.12 Merck
-
14.12.1 Merck Company Details
-
14.12.2 Merck Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Merck Oncology Cytotoxic Drug Product and Service
-
14.13 Sanofi
-
14.13.1 Sanofi Company Details
-
14.13.2 Sanofi Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Sanofi Oncology Cytotoxic Drug Product and Service
-
14.14 Novartis
-
14.14.1 Novartis Company Details
-
14.14.2 Novartis Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Novartis Oncology Cytotoxic Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncology Cytotoxic Drug
-
Figure Oncology Cytotoxic Drug Picture
-
Table Global Oncology Cytotoxic Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Cytotoxic Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Cytotoxic Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncology Cytotoxic Drug Consumption by Country (2017-2022)
-
Figure United States Oncology Cytotoxic Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Oncology Cytotoxic Drug Consumption and Growth Rate (2017-2022)
-
Figure China Oncology Cytotoxic Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncology Cytotoxic Drug Consumption and Growth Rate (2017-2022)
-
Figure India Oncology Cytotoxic Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncology Cytotoxic Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Cytotoxic Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Oncology Cytotoxic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncology Cytotoxic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncology Cytotoxic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncology Cytotoxic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncology Cytotoxic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncology Cytotoxic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Oral Dose Forms Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Oral Dose Forms Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncology Cytotoxic Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncology Cytotoxic Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Oncology Cytotoxic Drug Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Oncology Cytotoxic Drug Product and Service
-
Table Haosoh Pharma (Foundation Year, Company Profile and etc.)
-
Table Haosoh Pharma Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Haosoh Pharma Oncology Cytotoxic Drug Product and Service
-
Table Sumitomo Dainippon Pharma (Foundation Year, Company Profile and etc.)
-
Table Sumitomo Dainippon Pharma Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sumitomo Dainippon Pharma Oncology Cytotoxic Drug Product and Service
-
Table Jazz Pharma (Foundation Year, Company Profile and etc.)
-
Table Jazz Pharma Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jazz Pharma Oncology Cytotoxic Drug Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Oncology Cytotoxic Drug Product and Service
-
Table eisai (Foundation Year, Company Profile and etc.)
-
Table eisai Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table eisai Oncology Cytotoxic Drug Product and Service
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca Oncology Cytotoxic Drug Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Oncology Cytotoxic Drug Product and Service
-
Table Spectrum Pharma (Foundation Year, Company Profile and etc.)
-
Table Spectrum Pharma Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Pharma Oncology Cytotoxic Drug Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Oncology Cytotoxic Drug Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Oncology Cytotoxic Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Oncology Cytotoxic Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Oncology Cytotoxic Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oncology Cytotoxic Drug Product and Service
-
